The 12th ENCALS Meeting

The 12th ENCALS Meeting

A number of members of the Academic Unit of Neurology attended the annual conference of ENCALS (European Network for the Cure of ALS) at the University of Leuven, Belgium from May 22nd – 24th. The diverse program highlighted some of the exciting research being carried...

Funding for neuropsychology research

Recently Dr. Niall Pender, Principal Clinical Neuropsychologist at Beaumont Hospital, was awarded sizable research funding to further investigate very specific neuropsychological processes thought to decline as a result of Motor Neurone Disease. This research will...

Tirasemtiv Clinical Trial

The phase II Tirasemtiv clinical trial has recently been completed. The results are expected to be reported during the forthcoming American Academy of Neurology (AAN) conference in Philadelphia from April 26th to 3rd May 2014.  We would like to thank all our...
European Science TV and New Media Awards

European Science TV and New Media Awards

On the 22nd of November 2013, Professor Orla Hardiman delivered the keynote speech on Science, Medicine & the Media at the European and Science TV and New Media Awards which was held in Lisbon. She also successfully picked up the Best Presentation of/or by a Woman...

MND Research trial

We are recruiting for a Phase II clinical trial until October 2013. This is a multi-national study called BENEFIT-ALS. Tirasemtiv is a tablet being developed to improve skeletal muscle function in diseases associated with muscular weakness or fatigue. The clinical...